(Fowler's Diarrhea Tablets)
1 results
  • Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. [Randomized Controlled Trial]
    N Engl J Med. 2025 Jun 12; 392(22):2193-2202.Richeldi L, Azuma A, … FIBRONEER-IPF Trial Investigators
    ↓74
    NEJM
  • CONCLUSIONS: In patients with idiopathic pulmonary fibrosis, treatment with nerandomilast resulted in a smaller decline in the FVC than placebo over a period of 52 weeks. (Funded by Boehringer Ingelheim; FIBRONEER-IPF ClinicalTrials.gov number, NCT05321069.).
  • Publisher Full Text (DOI)